Human Gene Module / Chromosome 4 / NSD2

NSD2nuclear receptor binding SET domain protein 2

SFARI Gene Score
2S
Strong Candidate, Syndromic Criteria 2.1, Syndromic
Autism Reports / Total Reports
5 / 14
Rare Variants / Common Variants
38 / 0
Aliases
NSD2, KMT3F,  KMT3G,  MMSET,  REIIBP,  TRX5,  WHS,  WHSC1
Associated Syndromes
Wolf-Hirschhorn syndrome, Rauch-Steindl syndrome
Chromosome Band
4p16.3
Associated Disorders
DD/NDD, ID, ASD
Relevance to Autism

De novo likely gene-disruptive (dnLGD) variants in the NSD2 gene have been identified in an ASD proband from the Autism Sequencing Consortium (De Rubeis et al., 2014), an ASD proband from the SPARK cohort (Wang et al., 2020), and three probands from the Deciphering Developmental Disorders study in 2017, while de novo missense variants in this gene have been observed in an ASD proband from a multiplex family from the AGRE cohort (Yuen et al., 2017) and a proband with intellectual disability (Lelieveld et al., 2016). Single-molecular molecular inversion probe (smMIP) sequencing of 3,363 probands from cohorts with a primary diagnosis of ASD in Wang et al., 2020 identified three ASD-associated likely-gene disruptive variants and five ASD-associated missense variants with CADD scores 30 in the NSD2 gene. NSD2 is located with the critical region of Wolf-Hirschhorn syndrome (WHS), and numerous studies have reported that de novo truncating variants in this gene recapitulate many WHS-associated phenotypes (Boczek et al., 2018; Derar et al., 2019; Barrie et al., 2019; Jiang et al., 2019). Zanoni et al., 2021 reported 18 previously unpublished individuals from 16 families with ultrarare pathogenic or likely pathogenic variants in NSD2 that presented with a core phenotype characterized by mostly mild developmental delay, prenatal-onset growth retardation, low body mass index, and characteristic facial features distinct from those observed in individuals with Wolf-Hirschhorn syndrome; seven of these individuals presented with either a diagnosis of autism spectrum disorder or autistic features, and both individuals diagnosed with autism spectrum disorder in this report had de novo missense variants that were experimentally shown to reduce methylation activity and fail to reconstitute H3K36me2 levels in NSD2 knockout cells.

Molecular Function

This gene encodes a protein that contains four domains present in other developmental proteins: a PWWP domain, an HMG box, a SET domain, and a PHD-type zinc finger. It is expressed ubiquitously in early development. Wolf-Hirschhorn syndrome (WHS) is a malformation syndrome associated with a hemizygous deletion of the distal short arm of chromosome 4. This gene maps to the 165 kb WHS critical region and has also been involved in the chromosomal translocation t(4;14)(p16.3;q32.3) in multiple myelomas.

SFARI Genomic Platforms
Reports related to NSD2 (14 Reports)
# Type Title Author, Year Autism Report Associated Disorders
1 Support Synaptic, transcriptional and chromatin genes disrupted in autism De Rubeis S , et al. (2014) Yes -
2 Support Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability Lelieveld SH et al. (2016) No -
3 Support Prevalence and architecture of de novo mutations in developmental disorders et al. (2017) No -
4 Support Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder C Yuen RK et al. (2017) Yes -
5 Support De novo truncating variants in WHSC1 recapitulate the Wolf-Hirschhorn (4p16.3 microdeletion) syndrome phenotype Derar N et al. (2019) No -
6 Support Developmental delay and failure to thrive associated with a loss-of-function variant in WHSC1 (NSD2) Boczek NJ et al. (2018) No -
7 Support De novo loss-of-function variants in NSD2 ( WHSC1) associate with a subset of Wolf-Hirschhorn syndrome Barrie ES et al. (2019) No -
8 Support De novo truncating variant in NSD2gene leading to atypical Wolf-Hirschhorn syndrome phenotype Jiang Y et al. (2019) No -
9 Primary Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders Wang T et al. (2020) Yes DD
10 Recent Recommendation - Zanoni P et al. (2021) No ASD or autistic features, ID
11 Support - N.Y.) (07/2) Yes -
12 Support - Zhou X et al. (2022) Yes -
13 Support - Shiori Kinoshita et al. (2024) No -
14 Support - Shenglan Li et al. (2024) No -
Rare Variants   (38)
Status Allele Change Residue Change Variant Type Inheritance Pattern Parental Transmission Family Type PubMed ID Author, Year
c.*9_*11del - stop_lost Unknown - - 33004838 Wang T et al. (2020)
c.1881+6del - stop_lost Unknown - - 33004838 Wang T et al. (2020)
- - copy_number_loss Unknown - - 38593811 Shenglan Li et al. (2024)
c.1486G>T p.Glu496Ter stop_gained De novo - - 28135719 et al. (2017)
c.3575G>A p.Arg1192Gln missense_variant De novo - - 35901164 N.Y.) (07/2)
c.1348C>T p.Arg450Ter stop_gained Unknown - - 33004838 Wang T et al. (2020)
c.3412C>T p.Arg1138Ter stop_gained Unknown - - 33004838 Wang T et al. (2020)
c.2593G>A p.Gly865Ser missense_variant Unknown - - 33004838 Wang T et al. (2020)
c.2792C>T p.Thr931Met missense_variant Unknown - - 33004838 Wang T et al. (2020)
c.3518C>G p.Thr1173Arg missense_variant Unknown - - 33004838 Wang T et al. (2020)
c.3566C>T p.Thr1189Met missense_variant Unknown - - 33004838 Wang T et al. (2020)
c.3955G>A p.Gly1319Arg missense_variant Unknown - - 33004838 Wang T et al. (2020)
c.3530_3531del p.Phe1177Ter frameshift_variant De novo - - 28135719 et al. (2017)
c.3881C>A p.Ser1294Ter stop_gained De novo - Simplex 35982159 Zhou X et al. (2022)
c.1798C>T p.Arg600Ter stop_gained De novo - Simplex 33941880 Zanoni P et al. (2021)
c.2160T>A p.Cys720Ter stop_gained De novo - Simplex 33941880 Zanoni P et al. (2021)
c.2263C>T p.Arg755Ter stop_gained De novo - Simplex 33941880 Zanoni P et al. (2021)
c.253C>T p.Arg85Trp missense_variant Unknown - Simplex 33004838 Wang T et al. (2020)
c.769_770del p.Lys257GlufsTer12 frameshift_variant De novo - - 28135719 et al. (2017)
c.3410C>T p.Ser1137Phe missense_variant De novo - - 27479843 Lelieveld SH et al. (2016)
c.2606G>A p.Cys869Tyr missense_variant De novo - Simplex 33941880 Zanoni P et al. (2021)
c.3974A>G p.Glu1325Gly missense_variant Familial Paternal - 33004838 Wang T et al. (2020)
c.3380dup p.Ile1128AsnfsTer22 frameshift_variant De novo - - 33004838 Wang T et al. (2020)
c.3056A>G p.Lys1019Arg missense_variant De novo - Simplex 33941880 Zanoni P et al. (2021)
c.3271G>A p.Glu1091Lys missense_variant De novo - Simplex 33941880 Zanoni P et al. (2021)
c.3410C>T p.Ser1137Phe missense_variant De novo - Simplex 33941880 Zanoni P et al. (2021)
c.3301_3302delinsTG p.Glu1101Trp missense_variant Unknown - - 33004838 Wang T et al. (2020)
c.3992C>T p.Ala1331Val missense_variant De novo - Multiplex 28263302 C Yuen RK et al. (2017)
c.1370del p.Ala457AspfsTer16 frameshift_variant De novo - - 25363760 De Rubeis S , et al. (2014)
c.1569dup p.Lys524GlufsTer17 frameshift_variant De novo - Simplex 33941880 Zanoni P et al. (2021)
c.4028del p.Pro1343GlnfsTer49 frameshift_variant De novo - Simplex 33941880 Zanoni P et al. (2021)
c.4028delC p.Pro1343GlnfsTer49 frameshift_variant De novo - Simplex 33941880 Zanoni P et al. (2021)
c.2684C>T p.Pro895Leu missense_variant Familial Maternal Multiplex 33941880 Zanoni P et al. (2021)
c.1103_1104del p.Glu368ValfsTer13 frameshift_variant De novo - Simplex 33941880 Zanoni P et al. (2021)
c.1588_1589dup p.Ile532GlyfsTer67 frameshift_variant Unknown - Unknown 33941880 Zanoni P et al. (2021)
c.3547del p.Cys1183ValfsTer146 frameshift_variant Unknown Not maternal Simplex 33941880 Zanoni P et al. (2021)
c.3223_3226dup p.Gly1076ValfsTer16 frameshift_variant Unknown Not maternal Simplex 33941880 Zanoni P et al. (2021)
c.3472dup p.Asp1158GlyfsTer11 frameshift_variant Familial Paternal Extended multiplex 33941880 Zanoni P et al. (2021)
Common Variants  

No common variants reported.

SFARI Gene score
2S

Strong Candidate, Syndromic

Score Delta: Score remained at 2S

2

Strong Candidate

See all Category 2 Genes

We considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.

The syndromic category includes mutations that are associated with a substantial degree of increased risk and consistently linked to additional characteristics not required for an ASD diagnosis. If there is independent evidence implicating a gene in idiopathic ASD, it will be listed as "#S" (e.g., 2S, 3S, etc.). If there is no such independent evidence, the gene will be listed simply as "S."

4/1/2022
icon
2S

Increased from to 2S

Submit New Gene

Report an Error